Abstract
Analysis of the properties for individual hepatitis C virus (HCV) proteins makes it possible to establish their molecular structure and conformation, to localize antigenic and immunogenic determinants, to identify protective epitopes, and to solve applied problems (e.g., design of diagnostic tests, vaccines, and drugs). Linear and conformational epitopes of HCV proteins were localized using the phage display technique, and the peptides exposed on the phages selected with monoclonal antibodies against HCV proteins were tested for immunogenicity. Of the 11 epitopes revealed, three were strongly linear; two depended on the secondary; and one on the tertiary structure of the corresponding protein (conformational epitopes). Amino acid sequences involved in the other epitopes were established. The results can be used to improve the diagnosis of hepatitis C, to study the effect of amino acid substitutions on the antigenic properties of HCV proteins, and to analyze the immune response in patients infected with genotypically different HCV. It was shown with the example of the NS5A epitope that phage particles with epitope-mimicking peptides (mimotopes) induce production of antibodies against the corresponding HCV proteins.
Similar content being viewed by others
References
Laperche S., Courouce A.M. 1997. Development of a biological diagnosis for hepatitis C. Transfus. Clin. Biol. 4, 291–298.
Bartenschlager R., Lohmann V. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81, 1631–1648.
Moradpour D., Kary P., Rice C.M., Blum H.E. 1998. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology. 28, 193–201.
Chang J.C., Ruedinger B., Cong M., Lambert S., Lopareva E., Purdy M., Holloway B.P., Jue D.L., Ofenloch B., Fields H.A., Khudyakov Y.E. 1999. Artificial NS4 mosaic antigen of hepatitis C virus. J. Med. Virol. 59, 437–450.
Rosa C., Osborne S., Garetto F., Griva S., Rivella A., Calabresi G., Guaschino R., Bonelli F. 1995. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis. J. ViroI. Meth. 55, 219–232.
Courouce A.M., Noel L., Barin F., Elghouzzi M.H., Lunel F., North M.L., Smilovici W. 1998. A comparative evaluation of the sensitivity of five anti-hepatitis C virus immunoblot assays. Vox Sang. 74, 217–224.
Schwab C., Twardek A., Lo T.P., Brayer D., Bosshard H.R. 1993. Mapping antibody binding sites on cytochrome c with synthetic peptides: Are results representative of the antigenic structure of proteins? Protein Sci. 2, 175–182.
Pereboeva L.A., Pereboev A.V., Morris G.E. 1998. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries. J. Med. Virol. 56, 105–111.
Khudyakov Yu.E., Khudyakova N.S., Jue D.L., Lambert S.B., Fang S., Fields H.A. 1995. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology. 206, 666–672.
Jolivet-Reynaud C., Dalbon P., Viola F., Yvon S., Paranhos-Baccala G., Piga N., Bridon L., Trabaud M.A., Battail N., Sibai G., Jolivet M. 1998. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection. J. Med. Virol. 56, 300–309.
Scott J.K., Smith G.P. 1990. Searching for peptide ligands with an epitope library. Science. 249, 386–390.
Jolivet-Reynaud C., Adida A., Michel S., Deléage G., Paranhos-Baccala G., Gonin V., Battail-Poirot N., Lacoux X., Rolland D. 2004. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase. J. Med. Virol. 72, 385–395.
Prezzi C., Nuzzo M., Meola A., Delmastro P., Galfre G., Cortese R., Nicosia A., Monaci P. 1996. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156, 4504–4513.
Masalova O.V., Lakina E.I., Abdulmedzhidova A.G., Atanadze S.N., Semiletov Y.A., Shkurko T.V., Burkov A.N., Ulanova T.I., Pimenov V.K., Novikov V.V., Khudyakov Y.E., Fields H.A., Kushch A.A. 2002. Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus. Immunol. Lett. 83, 187–196.
Enshell-Seijffers D., Smelyanski L., Gershoni J.M. 2001. The rational design of a “type 88” genetically stable peptide display vector in the filamentous bacteriophage fd. Nucleic Acids Res. 29, 50–63.
Masalova O.V., Abdulmedzhidova A.G., Atanadze S.N., Lakina E.I., Semiletov Yu.A., Burkov A.N., Ulanova T.I., Novikov V.V., Pimenov V.K., Filds G., Khudyakov Yu.E., Kushch A.A. 2002. Characterization of a panel of monoclonal antibodies and the epitope mapping of hepatitis C virus proteins. Dokl. Akad. Nauk. 383, 545–550.
Enshell-Seijffers D., Denisov D., Groisman B., Smelyanski L., Meyuhas R., Gross G., Denisova G., Gershoni J.M. 2003. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J. Mol. Biol. 334, 87–101.
Pereboeva L.A., Pereboev A.V., Wang L.F., Morris G.E. 2000. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen. J. Med. Virol. 60, 144–151.
Ivanisenko V.A., Eroshkin A.M. 1997. Search for sites containing functionally significant substitutions in the sets of related or mutant proteins. Mol. Biol. 31, 880–887.
Ching W.-M., Wychowski C., Beach M.J., Wang H., Davies C.L., Carl M., Bradley D.W., Alter H.J., Feinstone S.M., Shin J.W.-K. 1992. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 89, 3190–3194.
Masalova O.V., Atanadze S.N., Kalinina T., Petrakova N.V., Smirnov V.D., Fields G., Khudyakov Yu.E., Kushch A.A. 1996. Immunochemical properties and specificity of monoclonal antibodies with respect to the N-and C-terminal regions of the recombinant hepatitis C virus nucleocapsid protein. Vopr. Virusol. 4, 150–156.
Masalova O.V., Kushch A.A. 2003. Monoclonal antibodies to hepatitis C proteins: A tool for mapping antigenic determinants, diagnosing hepatitis C, and studying viral pathogenesis. Ross. Bioterapevt. Zh. 3, 7–23.
Cerino A., Boender P., La Monica N., Rosa C., Habets W., Mondelli M.U. 1993. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J. Immunol. 151, 7005–7015.
Siemoneit K., Cardoso M.S., Wolp A., Koerner K., Subanek B. 1994. Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen. Hybridoma. 13, 9–13.
Menez R., Bossus M., Muller B.H., Sibai G., Dalbon P., Ducancel F., Jolivet-Reynaud C., Stura E.A. 2003. Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6. J. Immunol. 170, 1917–1924.
Mondelli M.U., Cerino A., Boender P., Oudshoorn P., Middeldorp J., Fipaldini C., La Monica N., Habets W. 1994. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J. Virol. 68, 4829–4836.
Chen M., Sallberg M., Sonnerborg A., Jin L., Birkett A., Peterson D., Weiland O., Milich D.R. 1998. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein. Hepatology. 28, 219–224.
Simmonds P., Rose K.A., Graham S., Chan S.-W., McOmish F., Dow B.C., Follett E.A.C., Yap P.L., Marsden H. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31, 1493–1503.
Chang J.C., Seidel C., Ofenloch B., Jue D.L., Fields H.A., Khudyakov Y.E. 1999. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides. Virology. 257, 177–190.
Garnier J., Osguthorpe D.J., Robson B. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120, 97–120.
Dou X.-G., Talekar G., Chang J., Dai X., Li L., Bonafonte M.-T., Holloway B., Fields H.A., Khudyakov Y.E. 2002. Antigenic heterogeneity of the hepatitis C virus NS5A protein. J. Clin. Microbiol. 40, 61–67.
Hopp T.P., Woods K.R. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA. 78, 3824–3828.
Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus Ib sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96, 224–230.
Bhattacherjee Y., Prescott L.F., Pike I., Rodgers B., Bell H., El-Zayadi A.R., Kew M.C., Conradie J., Lin C.K., Marsden H., Saeed A.A., Parker D., Yap P.L., Simmonds P. 1995. Use of NS4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76, 1737–1748.
Yip Y.L., Smith G., Ward R.L. 2001. Comparison of phage pIII, pVIII and GST as carrier proteins for peptide immunization in BALB/c mice. Immunol. Lett. 79, 197–202.
Meola A., Delmastro P., Monaci P., Luzzago A., Nicosia A., Felici F., Cortese R., Galfrl G. 1995. Derivation of vaccines from mimotopes: Immunologic properties of HBsAg mimotopes displayed on filamentous phage. J. Immunol. 154, 3162–3172.
Author information
Authors and Affiliations
Additional information
Original Russian Text © E.A. Rechkina, G.F. Denisova, O.V. Masalova, L.F. Lideman, D.A. Denisov, E.I. Lesnova, R.I. Ataullakhanov, S.V. Gurianova, A.A. Kushch, 2006, published in Molekulyarnaya Biologiya, 2006, Vol. 40, No. 2, pp. 357–368.
Rights and permissions
About this article
Cite this article
Rechkina, E.A., Denisova, G.F., Masalova, O.V. et al. Mapping of antigenic determinants of hepatitis C virus proteins using phage display. Mol Biol 40, 312–323 (2006). https://doi.org/10.1134/S002689330602018X
Received:
Issue Date:
DOI: https://doi.org/10.1134/S002689330602018X